Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain bypass device aims to give hand control back to paralyzed patients

NCT ID NCT03680872

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early study tests a device called the Bidirectional Neural Bypass System in up to 7 people with tetraplegia (paralysis from the neck down). The device is designed to let users move and feel their hand and wrist again by bypassing the damaged spinal cord. Researchers will measure improvements in movement and sensation during lab sessions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Bidirectional Neural Bypass System (implantable device)
What this could lead to
If successful, this device could help people with paralysis regain some hand movement and feeling, improving daily independence.
What could go wrong
This is a very early, small study with only 7 participants. The device is experimental and may not work for everyone, and risks from surgery or device use are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 7 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2019

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

22 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Males and females between 22 and 65 years of age 2. Individuals with a stable cervical spinal cord injury that have International Standards for the Neurological Classification of SCI (ISNCSCI) motor scores for fingers of 0 - 2 (non-functional) and ISNCSCI sensory scores of 0 - 2 (not normal) on the palmar side 3. Individuals at least one year from initial spinal cord injury 4. Individuals that are considered English Proficient due to the study requirements to follow verbal commands during testing sessions 5. Individuals that are able to comprehend the study goals and procedures, and are able to provide informed consent for participation. 6. Individuals that are willing and able to visit the study center for study procedures that will be 1-3 sessions a week for up to 48 months at 1-4 hours per session. 7. Have the ability and willingness to undergo upper limb electrodiagnostic and nerve conduction studies 8. Demonstrate typical amplitude, latency, and conduction velocity in the distal median, ulnar, and radial nerves of at least one upper limb Exclusion Criteria: 1. Individuals participating in another research study that may affect the conduct or results of this study 2. Individuals having or exhibiting any of the following: 1. Medical contraindications for diffusion tensor imaging, functional magnetic resonance imaging, electromyography, computed tomography, cortical stimulation, or craniotomies/surgeries 2. Prior difficulties or allergy to general anesthesia 3. Active wound healing or skin breakdown issues 4. Stage III-IV pressure ulcers 5. Chronically-implanted electronic medical device (e.g. baclofen pump, deep brain stimulator, epidural stimulator, cardiac pacemaker, vagus nerve stimulator, or other) 6. Prior tendon transfer to enhance hand function 7. History of autoimmune disease 8. Cancer 9. Biochemical abnormalities of the liver, kidney, or pancreas 10. Ventilator dependence 11. History of serious mood or thought disorder 12. Significant residual clinically evident traumatic brain injury or cognitive impairment 13. Uncontrolled autonomic dysreflexia 14. Spasticity in the upper extremities that is uncontrolled by pharmacological methods 15. Diagnosis of acute myocardial infarction or cardiac arrest within previous 6 months 16. Individuals with any type of destruction and/or damage to the motor cortex region as determined by fMRI. 17. History of a neurological ablation procedure 18. History of hemorrhagic stroke 19. History of infectious or chronic diseases, such as HIV or tuberculosis 3. Individuals with any of the following co-morbid conditions that would interfere with study activities or response to treatment: 1. Life expectancy \< 3 years 2. Severe chronic pulmonary disease 3. Intractable seizure disorders 4. Local, systemic acute or chronic infectious illness 5. Life threatening cardiac arrhythmias 6. Severe collagen vascular disorder 7. Kidney failure or other major organ systems failures 4. Individuals with a substance abuse (alcoholism or other) problem 5. Pregnant women 6. Prisoners

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Spinal cord injuries are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Northwell Health's The Feinstein Institute for Medical Research

    RECRUITING

    Manhasset, New York, 11030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.